Abstract:Personalized medicine uses fine grained information on individual persons, to pinpoint deviations from the normal. 'Digital Twins' in engineering provide a conceptual framework to analyze these emerging data-driven health care practices, as well as their conceptual and ethical implications for therapy, preventative care and human enhancement. Digital Twins stand for a specific engineering paradigm, where individual physical artifacts are paired with digital models that dynamically reflects the status of those artifacts. When applied to persons, Digital Twins are an emerging technology that builds on in silico representations of an individual that dynamically reflect molecular status, physiological status and life style over time. We use Digital Twins as the hypothesis that one would be in the possession of very detailed bio-physical and lifestyle information of a person over time. This perspective redefines the concept of 'normality' or 'health,' as a set of patterns that are regular for a particular individual, against the backdrop of patterns observed in the population. This perspective also will impact what is considered therapy and what is enhancement, as can be illustrated with the cases of the 'asymptomatic ill' and life extension via anti-aging medicine. These changes are the consequence of how meaning is derived, in case measurement data is available. Moral distinctions namely may be based on patterns found in these data and the meanings that are grafted on these patterns. Ethical and societal implications of Digital Twins are explored. Digital Twins imply a data-driven approach to health care. This approach has the potential to deliver significant societal benefits, and can function as a social equalizer, by allowing for effective equalizing enhancement interventions. It can as well though be a driver for inequality, given the fact that a Digital Twin might not be an accessible technology for everyone, and given the fact that patterns identified across a population of Digital Twins can lead to segmentation and discrimination. This duality calls for governance as this emerging technology matures, including measures that ensure transparency of data usage and derived benefits, and data privacy.

'Omics-Based Digital Twins for Personalised Paediatric Healthcare

Digital Twins: The New Frontier for Personalized Medicine?

Digital twins are integral to personalizing medicine and improving public health

Digital Twins: From Personalised Medicine to Precision Public Health

Patient digital twins: an introduction based on a scoping review

Human digital twin technology for individual profiling using LC-MS untargeted metabolomics analysis of dried blood spot samples

Digital Twins for More Precise and Personalized Treatment

Digital Twin Ecosystem for Oncology Clinical Operations

How paediatric drug development and use could benefit from OMICs: A c4c expert group white paper

Toward mechanistic medical digital twins: some use cases in immunology

Digital twins in dermatology, current status, and the road ahead

Immune digital twins for complex human pathologies: applications, limitations, and challenges

Envisioning the Future of Personalized Medicine: Role and Realities of Digital Twins

Digital Twins for Multiple Sclerosis

Digital Twins in Health Care: Ethical Implications of an Emerging Engineering Paradigm

Digital twins and artificial intelligence in metabolic disease research

Digital twin for healthcare systems

Digital twin concept: Healthcare, education, research

A Framework of Digital Twins for Improving Respiratory Health and Healthcare Measures

Biospecimen Digital Twins: Moving from a “High Quality” to a “Fit-for-Purpose” Concept in the Era of Omics Sciences

Exploring approaches for predictive cancer patient digital twins: Opportunities for collaboration and innovation